What is the expected overall cellularity in a bone marrow (BM) biopsy of a normal 70-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Bone Marrow Cellularity in a 70-Year-Old

The expected overall cellularity in a bone marrow biopsy of a normal 70-year-old is 30% ± 10, corresponding to answer choice D.

Age-Related Changes in Bone Marrow Cellularity

Bone marrow cellularity naturally decreases with age, following a predictable pattern:

  • In adults, bone marrow cellularity declines approximately 3% per decade 1
  • For individuals older than 60 years of age, the normal range is 30% to 60% with a mean of 45% and standard deviation of 15% 1
  • Specifically for those in their 70s, the mean cellularity is approximately 40% 2

Evidence-Based Normocellularity Ranges by Age

The most recent and comprehensive research provides the following age-adjusted normocellularity ranges:

  • Ages 20-40: 40-70% (mean 55% ± 15%)
  • Ages 40-60: 35-65% (mean 50% ± 15%)
  • Ages >60: 30-60% (mean 45% ± 15%) 1

Importantly, research has shown that individuals older than 70 years do not show a significant further decrease in cellularity compared to those aged 60-69 years 1. This contradicts older models that suggested a continuous linear decline with age.

Clinical Implications of Age-Adjusted Cellularity

Understanding normal age-related changes in bone marrow cellularity is critical for:

  • Avoiding misdiagnosis of hypocellular conditions like aplastic anemia
  • Correctly identifying hypercellular conditions like myeloproliferative neoplasms
  • Properly assessing bone marrow reserve in elderly patients

Without age adjustment, approximately 13% of AML patients and 29% of MDS patients might be incorrectly classified as having abnormal cellularity 3, 4.

Assessment Methods and Reliability

The most reliable method for determining bone marrow cellularity is through core biopsy examination:

  • Bone marrow biopsy is superior to aspirate or buffy coat examination for cellularity assessment 5
  • A 1-2 cm core biopsy is preferred for accurate evaluation 3
  • Digital image analysis methods show good correlation with pathologist assessment (ICC=0.78) 2

Common Pitfalls to Avoid

  1. Using the outdated "100% minus age in decades" formula, which overestimates the decline in cellularity
  2. Failing to account for the wide normal range (approximately 30-60%) in elderly patients
  3. Relying solely on aspirate samples, which can misrepresent true marrow cellularity in up to 39% of cases 5
  4. Not considering the increased apoptosis in elderly bone marrow, which contributes to hypocellularity 6

Therefore, when evaluating a bone marrow biopsy from a 70-year-old patient, the expected normal cellularity would be approximately 30% ± 10%, making answer choice D the correct option.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.